Tris Pharma

News

Tris Pharma has set its sights on an FDA filing for non-opioid pain drug cebranopadol this year after hitting the mark in an abdominoplasty trial.

News

Using Claude Science, Claude agents designed high-affinity protein binders for a range of targets, outperforming human experts in some cases.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.